COVID-19 Vaccination in Patients With Malignancy; A Systematic Review and Meta-Analysis of the Efficacy and Safety

BACKGROUND: Data on the efficacy and safety of COVID-19 vaccines in patients with malignancy are immature. In this paper, we assessed the literature involving the use of COVID-19 vaccines in cancer patients and reported the seroconversion rates as the main outcome and severity of COVID-19 infection...

Descripción completa

Detalles Bibliográficos
Autores principales: Javadinia, Seyed Alireza, Alizadeh, Kimia, Mojadadi, Mohammad-Shafi, Nikbakht, Fateme, Dashti, Farzaneh, Joudi, Maryam, Harati, Hadi, Welsh, James S., Farahmand, Seyed Amir, Attarian, Fahimeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108702/
https://www.ncbi.nlm.nih.gov/pubmed/35586627
http://dx.doi.org/10.3389/fendo.2022.860238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108702/
https://www.ncbi.nlm.nih.gov/pubmed/35586627
http://dx.doi.org/10.3389/fendo.2022.860238

Ejemplares similares